insidealerts.com
Did the insiders get it right?
Every open-market Form 4 buy (code P) and sale (code S), joined to daily prices. A purchase scores a positive return if the stock rose; a sale scores a positive return if the stock fell.
Latest open-market trades
Shares and value come from the Form 4. Recent prints do not yet have their own 90- or 180-day returns; those columns then show that insider’s average completed history, marked hist.
| Date | Form 4 | Ticker | Insider | Title | Side | Shares | Value | 90d | 180d |
|---|---|---|---|---|---|---|---|---|---|
| 9/18/2026 | Form 4 | BNTX 10b5-1 | Sahin Ugur | Chief Executive Officer | SELL | 30,000 | $2.89M | — | — |
| 9/18/2026 | Form 4 | BSQKZ 10b5-1 | Eisen Anthony MathewMr. Eisen has served as the Chief Executive Officer of Reshop US, Inc. (“Reshop”) where he also serves as Chairman of the Board. Prior to becoming Chief Executive Officer of Reshop, Mr. Eisen served as Block’s co-lead of Afterpay from January 2022, when Block acquired Afterpay Limited (“Afterpay”), to November 2024 and served as a consultant to aid in the transition of his duties until his election to our board of directors. Prior to the acquisition of Afterpay, Mr. Eisen served as the co-Chief Executive Officer and a member of the board of directors of Afterpay, which he co-founded in November 2014. Mr. Eisen currently serves on the board of directors of the Technology Council of Australia. Mr. Eisen holds… | Director | SELL | 6,000 | $459.3K | −27.1%hist | — |
| 9/18/2026 | Form 4 | MARA 10b5-1 | Nowaid ZabiZabi Nowaid has served as General Counsel and Corporate Secretary of MARA since October 2, 2023, where he leads the Company’s global legal strategy and oversees all aspects of its legal and corporate governance functions. Mr. Nowaid is a member of the executive leadership team and has played a central role in shaping MARA’s growth trajectory by leading and advising on the Company’s most significant and transformational transactions, strategic initiatives and commercial arrangements across its digital infrastructure and platform. Prior to joining MARA, Mr. Nowaid served as Senior Vice President, General Counsel and Corporate Secretary of Open English, a global education technology company backed by TCV and… | General Counsel | SELL | 8,376 | $101.3K | +23.4%hist | +9.45%hist |
| 9/18/2026 | Form 4 | NUTX | Saunders Scott J | Director | SELL | 203 | $43.5K | — | — |
| 9/18/2026 | Form 4 | HTFL 10b5-1 | Verghese VikramVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | Chief Financial Officer | SELL | 16,766 | $850.9K | — | — |
| 9/18/2026 | Form 4 | BX | Baratta Joseph | Director | SELL | 57,754 | $7.17M | −4.35%hist | −6.64%hist |
| 9/18/2026 | Form 4 | BX | Baratta Joseph | Director | SELL | 42,246 | $5.21M | −4.35%hist | −6.64%hist |
| 9/18/2026 | Form 4 | DSP 10b5-1 | MADDEN LARRYLarry Madden has served as our Chief Financial Officer since October 2020 and has served as the chief financial officer of Viant Technology LLC since September 2012. Before joining Viant Technology LLC, Mr. Madden served as chief financial officer of a number of media and technology companies starting in 1995. Mr. Madden has extensive public company experience, including as chief financial officer of two Nasdaq-listed companies and as a board member of a third Nasdaq-listed company. He has served on the board of directors of Outdoorsy, Holdings, a private travel-and-insurtech platform company, since August 2021. Mr. Madden started his career at Ernst & Young where he spent nearly eight years. Mr. Madden is… | Chief Financial Officer | SELL | 14,602 | $176.7K | −24.6%hist | −2.12%hist |
| 9/18/2026 | Form 4 | SYNA 10b5-1 | Bodensteiner Lisa | Officer | SELL | 334 | $30.9K | −13.8%hist | −59.7%hist |
| 9/18/2026 | Form 4 | CSHR 10b5-1 | Masters Daniel | 10% owner and Director | SELL | 60,790 | $327.5K | — | — |
| 9/18/2026 | Form 4 | CBIO 10b5-1 | Brumm Joshua TMr. Brumm has served as our Chief Executive Officer and as a member of our Board since March 2025. Prior to joining us, Mr. Brumm was a General Partner at Forbion, a leading life sciences investment firm, from June 2024 to March 2025. From October 2019 to March 2024, Mr. Brumm served as Chief Executive Officer and President and as a director of Dyne Therapeutics, Inc. (Nasdaq: DYN), a biotechnology company. Prior to joining Dyne Therapeutics, Mr. Brumm served as Chief Operating Officer and Chief Financial Officer at Kaleido Biosciences, Inc. (formerly, Nasdaq: KLDO), a healthcare company, from April 2018 to October 2019. Prior to joining Kaleido, Mr. Brumm served as Chief Operating Officer and Chief… | Chief Executive Officer | SELL | 7,837 | $131.0K | −20.1%hist | −45.2%hist |
| 9/18/2026 | Form 4 | CBIO 10b5-1 | McNeill JonathanDr. McNeill has served as our Chief Operating Officer and President since March 2025. Prior to joining us, Dr. McNeill was a Partner at Forbion, a leading life sciences investment firm, from January 2025 to March 2025. From February 2019 to September 2024, Dr. McNeill held roles of increasing responsibility at Dyne Therapeutics, Inc. (Nasdaq: DYN), a biotechnology company, where he served as Chief Business Officer from July 2023 to September 2024, Senior Vice President, Business Development from July 2021 to July 2023, and as Vice President, Business Development from February 2019 to June 2021. Prior to joining Dyne Therapeutics, Dr. McNeill served as Associate Director, Business Development at Editas… | President and COO | SELL | 3,839 | $64.1K | −17.7%hist | −41.7%hist |
| 9/18/2026 | Form 4 | SYNA 10b5-1 | Song Esther | Officer | SELL | 63 | $5.8K | +33.7%hist | — |
| 9/18/2026 | Form 4 | THRY | Walsh JoeMr. Walsh has served as our Chairman in addition to serving as our Chief Executive Officer, and Mr. Slater has served as Lead Independent Director. The Board of Directors believes that this structure is effective and best for the Company at this point in time for several reasons. Mr. Walsh has been our Chief Executive Officer and a director since October 2014. Mr. Walsh also holds a significant number of shares of our common stock. The Board of Directors believes that as a long-term executive officer, director and significant stockholder, Mr. Walsh is well qualified to serve as our Chairman and Chief Executive Officer, and his interests are aligned with those of our stockholders. Furthermore, Mr. Walsh has… | Chairman and CEO | BUY | 25,000 | $45.0K | +1.08%hist | −10.5%hist |
| 9/18/2026 | Form 4 | HRMY | Budur KumarDr. Budur has served as our Chief Medical Officer since May 2023. Previously, Dr. Budur was the Executive Medical Director at AbbVie Inc., a public biopharmaceuticals company, from August 2015 to February 2022. Prior to this, Dr. Kumar held positions of increasing responsibilities for six years at Takeda Pharmaceutical Company Limited, a global, research and development-driven pharmaceutical company. A nationally recognized expert in Research and Development, he has overseen programs ranging from late discovery, early clinical development to late clinical development, and post-marketing studies. He has experience in progressing small molecules, biologics, drug-device combination through various stages of… | CHIEF MEDICAL OFFICER | SELL | 35,852 | $1.54M | — | — |
| 9/18/2026 | Form 4 | PGY 10b5-1 | Rosen Tami | Director | SELL | 8,504 | $173.3K | — | — |
| 9/18/2026 | Form 4 | LITE 10b5-1 | Wupen Yuen | PRESIDENT, GLOBAL BUS. UNITS | SELL | 500 | $460.0K | −84.7%hist | −61.4%hist |
| 9/18/2026 | Form 4 | DLHC | Mink Brook Asset Management LLC | 10% owner | BUY | 316 | $1.2K | +5.41%hist | +10.9%hist |
| 9/18/2026 | Form 4 | LIFE 10b5-1 | Colis Peter George | CEO and Secretary | SELL | 7,190 | $258.7K | −60.3%hist | — |
| 9/18/2026 | Form 4 | LIFE 10b5-1 | Colis Peter George | CEO and Secretary | SELL | 9,648 | $357.5K | −60.3%hist | — |
| 9/18/2026 | Form 4 | LIFE 10b5-1 | Colis Peter George | CEO and Secretary | SELL | 6,495 | $243.7K | −60.3%hist | — |
| 9/18/2026 | Form 4 | TH | Schrenk Troy C.TROY C. SCHRENK has served as our Chief Commercial Officer since 2018 and as Senior Executive Vice President Operations & Chief Commercial Officer since January 2024. In this role, he is responsible for leading the Company’s business and commercial operations, construction, business development, and government relations. Mr. Schrenk joined Target in 2012 as Senior Vice President. ■ He has over twenty years of experience in modular manufacturing, specialty rentals, home building and real estate development, Mr. Schrenk is a proven commercial leader with a track record of success in revenue and strategic growth management which began with Fortune 500, Centex Homes (NYSE: CTX) from 2000 – 2005 as Area Sales… | Chief Commercial Officer | BUY | 5,907 | $125.0K | +7.01%hist | −4.69%hist |
| 9/18/2026 | Form 4 | MHK | HELEN SUZANNE L | Other | SELL | 800 | $100.5K | −1.69%hist | −4.29%hist |
| 9/18/2026 | Form 4 | GAM-PB | Priest Jeffrey W | President & CEO | BUY | 4,000 | $93.8K | — | — |
| 9/17/2026 | Form 4 | CAI | Brille Brian J | Director and Officer | SELL | 400,000 | $12.13M | +22.7%hist | −0.22%hist |
| 9/17/2026 | Form 4 | VG 10b5-1 | Larson Keith D | General Counsel and Secretary | SELL | 394,979 | $5.69M | +0.83%hist | −14.5%hist |
| 9/17/2026 | Form 4 | GENI | Locke Mark | Chief Executive Officer | SELL | 50,000 | $327.1K | — | — |
| 9/17/2026 | Form 4 | CRCT 10b5-1 | Ashish Arora | Chief Executive Officer | SELL | 60,000 | $340.5K | +4.79%hist | +6.56%hist |
| 9/17/2026 | Form 4 | LIFE 10b5-1 | Wang Lingke | President | SELL | 315 | $12.5K | −60.3%hist | — |
| 9/17/2026 | Form 4 | LIFE 10b5-1 | Wang Lingke | President | SELL | 110,587 | $4.31M | −60.3%hist | — |
| 9/17/2026 | Form 4 | LIFE 10b5-1 | Wang Lingke | President | SELL | 7,431 | $285.1K | −60.3%hist | — |
| 9/17/2026 | Form 4 | BNTX 10b5-1 | Sahin Ugur | Chief Executive Officer | SELL | 34,000 | $3.35M | — | — |
| 9/17/2026 | Form 4 | HIMS 10b5-1 | Okupe Oluyemi | Chief Financial Officer | SELL | 12,313 | $354.9K | −22.6%hist | −47.0%hist |
| 9/17/2026 | Form 4 | CGC | Stewart Thomas CarltonThomas Stewart has served as Canopy Growth’s CFO since September 17, 2025. Prior to his appointment as CFO, Mr. Stewart served as Canopy Growth’s interim Chief Financial Officer since July 2025 and had been a member of the Company’s senior finance leadership team since joining the Company in 2019 as Chief Accounting Officer, a position in which Mr. Stewart oversaw a wide range of finance functions, including accounting, transactional services, external reporting, tax, financial planning and analysis, commercial finance, and operations finance. He has played a key role in building Canopy Growth’s finance function and navigating the Company through significant transformation. Mr. Stewart is a seasoned finance… | Officer | SELL | 25,755 | $24.0K | −22.3%hist | −1.24%hist |
| 9/17/2026 | Form 4 | GFS 10b5-1 | Azar Samak L | Chief Legal Officer | SELL | 335 | $15.0K | +0.11%hist | +1.26%hist |
| 9/17/2026 | Form 4 | PBI-PB 10b5-1 | Wolf Kurt JamesMr. Wolf has served as the Principal Executive Officer (“PEO”) since May 22, 2025. Prior to this, Mr. Rosenzweig served as the PEO from May 22, 2024; first as Interim CEO and then as CEO as of October 25, 2024. Mr. Dies served as the PEO from October 2, 2023 through May 21, 2024. Mr. Lautenbach served as the PEO January 1, 2023 through October 1, 2023, and for the entirety of 2022 and 2021. Non-PEO NEOs for the applicable fiscal years are as follows: - 2025: Paul Evans, Deborah Pfeiffer, Lauren Freeman-Bosworth, Todd Everett, Robert Gold, John Witek, James Fairweather, and Shemin Nurmohamed - 2024: John Witek, James Fairweather, Shemin Nurmohamed, Deborah Pfeiffer, Ana Chadwick, Gregg Zegras, and Daniel… | President & CEO | SELL | 2,150 | $37.5K | −1.65%hist | −5.33%hist |
| 9/17/2026 | Form 4 | PBI-PB 10b5-1 | Wolf Kurt JamesMr. Wolf has served as the Principal Executive Officer (“PEO”) since May 22, 2025. Prior to this, Mr. Rosenzweig served as the PEO from May 22, 2024; first as Interim CEO and then as CEO as of October 25, 2024. Mr. Dies served as the PEO from October 2, 2023 through May 21, 2024. Mr. Lautenbach served as the PEO January 1, 2023 through October 1, 2023, and for the entirety of 2022 and 2021. Non-PEO NEOs for the applicable fiscal years are as follows: - 2025: Paul Evans, Deborah Pfeiffer, Lauren Freeman-Bosworth, Todd Everett, Robert Gold, John Witek, James Fairweather, and Shemin Nurmohamed - 2024: John Witek, James Fairweather, Shemin Nurmohamed, Deborah Pfeiffer, Ana Chadwick, Gregg Zegras, and Daniel… | President & CEO | SELL | 21,737 | $378.9K | −1.65%hist | −5.33%hist |
| 9/17/2026 | Form 4 | BZUN | Qiu Wenbin | Chief Executive Officer | BUY | 7,100 | $20.2K | +4.66%hist | — |
| 9/17/2026 | Form 4 | NTNX 10b5-1 | Sivaraman RukminiRukmini Sivaraman has served as our Chief Financial Officer since May 2022. Ms. Sivaraman previously served as our Senior Vice President, FP&A and Strategic Finance from January 2022 to May 2022. Prior to that, she served in various leadership roles at our company, including as Senior Vice President of Strategic Finance, Chief People Officer, and Senior Vice President of People and Business Operations. Prior to joining us, Ms. Sivaraman served as an investment banker at Goldman Sachs from June 2009 to March 2017. Ms. Sivaraman holds an M.B.A. from the Kellogg School of Management at Northwestern University and an M.S. in Electrical Engineering from the University of Michigan at Ann Arbor. Brian Martin has… | Chief Financial Officer | SELL | 38,139 | $2.67M | −8.93%hist | −16.0%hist |
| 9/17/2026 | Form 4 | KRNY | Wong-Zaza Melvina | Director | BUY | 1,560 | $15.0K | +3.88%hist | +6.56%hist |
| 9/17/2026 | Form 4 | PL 10b5-1 | Johnson Ashley F. | President & CFO | SELL | 55,663 | $944.3K | +10.4%hist | +23.3%hist |
| 9/17/2026 | Form 4 | MASS 10b5-1 | Kenneweg John | SVP, Sales & Product Marketing | SELL | 5,257 | $53.7K | +12.9%hist | +33.1%hist |
| 9/17/2026 | Form 4 | WLTH 10b5-1 | Imberman AlanAlan Imberman has served as our Chief Financial Officer and Treasurer since April 2021. Since October 2015, Mr. Imberman has served in roles of increasing responsibility at Wealthfront, including most recently as Vice President of Finance from July 2019 to April 2021. Prior to joining Wealthfront, Mr. Imberman served as Senior Manager at Crowe LLP, a public accounting and consulting firm, from July 2014 until October 2015 and Senior Manager at KPMG US LLP, an advisory firm, from November 2006 until July 2014. Mr. Imberman earned a B.S. in Finance from the University of Texas at Dallas and an M.B.A. from the University of Texas at Austin and is a CFA Charterholder. Kal Iyer has served as our Vice President… | CFO and Treasurer | SELL | 76,540 | $773.3K | — | — |
| 9/17/2026 | Form 4 | WLTH 10b5-1 | Wetterwald JulienMr. Wetterwald has served in roles of increasing responsibility at Wealthfront, including as Distinguished Software Engineer from February 2015 to September 2019, and in various software engineering capacities, ultimately as Principal Software Engineer, from July 2009 to July 2012. He previously served as Principal Software Engineer at Wonga.com Limited, a financial services company, from October 2012 to February 2015. Mr. Wetterwald earned a B.S. in Computer Science from École Polytechnique Fédérale de Lausanne and an M.S. in Computer Science from Stanford University. 26 Executive Compensation The following tables and accompanying narrative disclosure set forth information about the compensation earned by… | Chief Technology Officer | SELL | 26,138 | $264.1K | −28.9%hist | — |
| 9/17/2026 | Form 4 | QUIK | Faith Brian CMr. Faith has served on the board of the Global Semiconductor Alliance (GSA) and previously served as Chairman of the Marketing Committee for the CE-ATA Organization. He holds a Bachelor of Science degree in Computer Engineering from Santa Clara University and has served as an Adjunct Lecturer at Santa Clara University, teaching courses related to programmable logic. Ron Shelton is a seasoned financial executive with more than 30 years of financial and operational leadership experience spanning both publicly traded companies to privately held startups. His expertise includes financial strategy, operational efficiency, and governance across the semiconductor and technology sectors. Currently, he serves as… | PRESIDENT AND CEO | SELL | 17,255 | $176.2K | −7.24%hist | −3.94%hist |
| 9/17/2026 | Form 4 | BSQKZ 10b5-1 | Eisen Anthony MathewMr. Eisen has served as the Chief Executive Officer of Reshop US, Inc. (“Reshop”) where he also serves as Chairman of the Board. Prior to becoming Chief Executive Officer of Reshop, Mr. Eisen served as Block’s co-lead of Afterpay from January 2022, when Block acquired Afterpay Limited (“Afterpay”), to November 2024 and served as a consultant to aid in the transition of his duties until his election to our board of directors. Prior to the acquisition of Afterpay, Mr. Eisen served as the co-Chief Executive Officer and a member of the board of directors of Afterpay, which he co-founded in November 2014. Mr. Eisen currently serves on the board of directors of the Technology Council of Australia. Mr. Eisen holds… | Director | SELL | 6,000 | $467.8K | −27.1%hist | — |
| 9/17/2026 | Form 4 | MARA 10b5-1 | Thiel Frederick G | Chief Executive Officer | SELL | 27,505 | $314.9K | +12.1%hist | +19.2%hist |
| 9/17/2026 | Form 4 | MARA 10b5-1 | Khan Salman HassanSalman Khan has served as Chief Financial Officer since June 14, 2023. Mr. Khan oversees a broad set of enterprise functions beyond traditional financial oversight, including legal, information technology, investor relations, treasury, digital asset management, internal audit, tax, accounting and financial planning and analysis. His responsibilities have also encompassed corporate development, including MARA's M&A and strategic partnership efforts. He also serves as a MARA-appointed director on the board of Exaion, the Company's European digital infrastructure subsidiary. Since joining MARA, Mr. Khan has led over $5 billion in capital markets and balance sheet transactions. Mr. Khan also led the transition… | Chief Financial Officer | SELL | 16,000 | $183.2K | +3.72%hist | +12.4%hist |
| 9/17/2026 | Form 4 | STNG | Adelborg Auste | Secretary | SELL | 6,834 | $612.6K | — | — |
| 9/17/2026 | Form 4 | STNG | Mackey Cameron Keyser | Chief Operating Officer | SELL | 125,000 | $11.13M | — | — |
| 9/17/2026 | Form 4 | GNRC 10b5-1 | Raabe Kyle Andrew | President, Home Power Gen. | SELL | 213 | $48.9K | −38.6%hist | −22.9%hist |
| 9/17/2026 | Form 4 | GNRC 10b5-1 | Raabe Kyle Andrew | President, Home Power Gen. | SELL | 390 | $89.5K | −38.6%hist | −22.9%hist |
| 9/17/2026 | Form 4 | NEGG | CHANG FRED FACHING | 10% owner and Director | SELL | 28,500 | $371.9K | +23.1%hist | — |
| 9/17/2026 | Form 4 | HTFL 10b5-1 | Verghese VikramVikram Verghese has served as our Chief Financial Officer since June 2023. He joined the Company in November 2021 as Senior Vice President of Upstream Marketing, Business Development, and Strategy. Prior to that, Mr. Verghese held various positions at Medtronic from 2008 until 2021 in various leadership roles spanning global marketing, regulatory and clinical affairs and business development. After completing his undergraduate degree in Electrical and Electronic Engineering in India, Mr. Verghese received an M.S. in Biomedical Engineering from the University of Southern California and an M.B.A. from University of Pennsylvania’s The Wharton School. He is also a CFA charter holder. Campbell D.K. Rogers, M.D.… | Chief Financial Officer | SELL | 7,579 | $379.8K | — | — |
| 9/17/2026 | Form 4 | AIM | Equels Thomas K | CEO & President | BUY | 24,000 | $5.0K | −15.2%hist | −37.6%hist |
| 9/17/2026 | Form 4 | TVTX 10b5-1 | Dube Eric MDr. Dube has served on the Board of Directors for the Biotechnology Innovation Organization (BIO) since June 2022. Previously, Dr. Dube served on the Board of Trustees for AIDS United, on the Board of Directors for Biocom California, and on the Board of Directors for Reneo Pharmaceuticals, Inc. from March 2021 to October 2024. Dr. Dube holds a B.S. from Santa Clara University and a M.A. and Ph.D. from Cornell University. Dr. Dube was selected as a director because of his business and professional experience and extensive drug development and commercialization experience . Gary Lyons has served as a director of the Company since October 2014 and Chair of the Company since May 2016. Mr. Lyons was the founding… | CHIEF EXECUTIVE OFFICER | SELL | 6,802 | $441.8K | −9.25%hist | −10.5%hist |
| 9/17/2026 | Form 4 | TVTX 10b5-1 | Dube Eric MDr. Dube has served on the Board of Directors for the Biotechnology Innovation Organization (BIO) since June 2022. Previously, Dr. Dube served on the Board of Trustees for AIDS United, on the Board of Directors for Biocom California, and on the Board of Directors for Reneo Pharmaceuticals, Inc. from March 2021 to October 2024. Dr. Dube holds a B.S. from Santa Clara University and a M.A. and Ph.D. from Cornell University. Dr. Dube was selected as a director because of his business and professional experience and extensive drug development and commercialization experience . Gary Lyons has served as a director of the Company since October 2014 and Chair of the Company since May 2016. Mr. Lyons was the founding… | CHIEF EXECUTIVE OFFICER | SELL | 101,691 | $6.57M | −9.25%hist | −10.5%hist |
| 9/17/2026 | Form 4 | PLAY | Lipman Nathaniel | Director | BUY | 12,000 | $81.3K | — | — |
| 9/17/2026 | Form 4 | MGNI 10b5-1 | Caine PaulMr. Caine has served as President, On Location at TKO Group Holdings, Inc. (formerly part of Endeavor Group Holdings, Inc.), a sports and entertainment company, since January 2020. Mr. Caine served as President, IMG Events, an event management services company, from August 2022 to March 2025, the Chairman and Executive Director of the Board of Engine Group, a global marketing company, from January 2018 to February 2023, and as CEO and Founder of PC Ventures, LLC, an investment and advisory firm, since August 2017. Mr. Caine served as the Chief Global Revenue Officer for Bloomberg Media from June 2014 to July 2016. From April 2013 to January 2014, he served as Chief Executive Officer and a member of the… | Director | SELL | 7,500 | $198.8K | +14.2%hist | +35.5%hist |
| 9/17/2026 | Form 4 | DOGP | TOBIAS DAVID | CEO | SELL | 180,000 | $1.8K | +18.1%hist | +29.8%hist |
Prices are split-adjusted closes. Returns use the last close on or before the trade date and the first close on or after 90 and 180 calendar days. Sales are signed so a declining price is a positive result for the seller. Not investment advice. Source: SEC Form 3/4/5 extracts and EDGAR, Yahoo Finance daily bars. Sectors are the SEC’s industry office for the issuer.